Severe Bullous Drug Eruption and Filgrastim

Clinical trial NCT04651439 · UNKNOWN

Trial details

NCT number: NCT04651439
Sponsor: Hospices Civils de Lyon
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Rare Diseases Toxic Epidermal Necrolyses

Start date: 2022-05-13
Primary completion: 2025-05-18
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.